Informacje dodatkowe
| Active substance | Amlodipine |
|---|---|
| Formula | C20H25ClN2O5 |
| Side effects | Headache, swelling, fatigue, abdominal pain, dizziness |
| Effects | Lowering blood pressure, increasing blood flow |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 5 mg once daily, may be increased to 10 mg depending on patient response |
| Half-life | 30-50 hours |
| Main action | Vasodilator |
| Substance class | Calcium channel blocker |
| Chemical name | 3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Storage conditions | Store at room temperature away from moisture and light |
| Trade name | Norvasc, among others |
| Blood pressure | Reduces blood pressure |
| WAREHOUSE | International Warehouse 2 |
| Also known as | Amlodipine besylate (when combined with besylate salt) |
| Lab Test | Not typically required |
| Hepatotoxicity | Low risk |
| Water Retention | Can cause mild water retention |
| Use in sports | Not typically used in sports |
| Manufacturer | Pfizer |
|
Opinie
Na razie nie ma opinii o produkcie.